TY - JOUR
T1 - Myocarditis
T2 - Infection versus autoimmunity
AU - Rose, Noel R.
N1 - Funding Information:
Acknowledgements The author’s research was supported by NIH grants R01HL067290 and R01HL077611. He thanks Mrs. Starlene Murray for excellent editorial assistance.
PY - 2009/11
Y1 - 2009/11
N2 - Introduction: Myocarditis, which is the inflammation of the heart muscle, remains a vexing therapeutic problem. Many cases are associated with viral infection, and appropriate treatment may depend upon whether the disease is primarily infectious, immune-mediated, or both. Discussion: The combination of endomyocardial biopsies with newer molecular and immunologic tools holds a promise of distinguishing the different etiologies of myocarditis, thus, guiding future treatments. Nucleic acid hybridization and polymerase chain reaction have been applied to detect viral genome persisting in the heart. Early trials with type 1 interferons have shown a promise in patients with biopsy-proven enteroviral infection. Antibodies to cardiac antigens and increased HLA expression in cardiac biopsies have been used to identify patients, most likely, to benefit from immunosuppression or immunoadsorption. Future advances in the therapy of inflammatory disease of the heart may be based on detailed studies of myocarditis in animal models. Using coxsackievirus B3 infection or cardiac myosin immunization, we have identified some critical steps leading from a self-limited viral myocarditis to chronic autoimmune myocarditis and sometimes, to dilated cardiomyopathy. Conclusion: Myocarditis offers an opportunity to dissect the complex interaction between a viral infection and an autoimmune disease. The lessons learned from investigations in humans and in animal models hold a promise that may lead the way to improved treatments.
AB - Introduction: Myocarditis, which is the inflammation of the heart muscle, remains a vexing therapeutic problem. Many cases are associated with viral infection, and appropriate treatment may depend upon whether the disease is primarily infectious, immune-mediated, or both. Discussion: The combination of endomyocardial biopsies with newer molecular and immunologic tools holds a promise of distinguishing the different etiologies of myocarditis, thus, guiding future treatments. Nucleic acid hybridization and polymerase chain reaction have been applied to detect viral genome persisting in the heart. Early trials with type 1 interferons have shown a promise in patients with biopsy-proven enteroviral infection. Antibodies to cardiac antigens and increased HLA expression in cardiac biopsies have been used to identify patients, most likely, to benefit from immunosuppression or immunoadsorption. Future advances in the therapy of inflammatory disease of the heart may be based on detailed studies of myocarditis in animal models. Using coxsackievirus B3 infection or cardiac myosin immunization, we have identified some critical steps leading from a self-limited viral myocarditis to chronic autoimmune myocarditis and sometimes, to dilated cardiomyopathy. Conclusion: Myocarditis offers an opportunity to dissect the complex interaction between a viral infection and an autoimmune disease. The lessons learned from investigations in humans and in animal models hold a promise that may lead the way to improved treatments.
KW - Autoimmunity
KW - Cardiomyopathy
KW - Myocarditis
UR - http://www.scopus.com/inward/record.url?scp=72849146371&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=72849146371&partnerID=8YFLogxK
U2 - 10.1007/s10875-009-9339-z
DO - 10.1007/s10875-009-9339-z
M3 - Review article
C2 - 19826933
AN - SCOPUS:72849146371
SN - 0271-9142
VL - 29
SP - 730
EP - 737
JO - Journal of Clinical Immunology
JF - Journal of Clinical Immunology
IS - 6
ER -